At Harvard Business School, Dr Feeley works with Professors Michael Porter and Robert Kaplan on their value-based health care agenda, with an emphasis on the role of information technology. He is also the Head of the Institute for Cancer Care Innovation at MD Anderson, where his work focuses on demonstrating and improving the value of cancer care.
Dr. Feeley recently served on the Institute of Medicine’s Committee on Improving the Quality of Cancer Care, which in 2013 released the report Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis.
Dr. Feeley received both his undergraduate and medical degrees from Boston University and trained in anesthesiology and critical care at Boston’s Beth Israel Hospital. He was a faculty member at Stanford University for 19 years, practicing cardiovascular anesthesia and critical care.
Andrea L. Pusic, MD, MHS, FACS, FRCSC, completed her medical degree at the Cumming School of Medicine (University of Calgary) in Canada and master of public health at Johns Hopkins University. She completed a general surgery residency at Dalhousie University in Nova Scotia, and a plastic surgery residency at McGill University in Montreal, followed by a plastic and reconstructive surgery fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr. Pusic was most recently an attending plastic surgeon at MSKCC and a professor of surgery at Weill Medical College of Cornell University in New York, NY.
Dr. Pusic is an internationally-renowned innovator and leader in the area of patient-reported outcomes and surgical experience. This is increasingly important in the current health care environment of measuring quality, assessing value and ultimately, influencing how health care is funded. Dr. Pusic will lead the newly formed Patient-Reported Outcomes, Value & Experience (PROVE) Center at Brigham Health. The scope of the PROVE Center will be focused on patient-reported outcomes, patient experience and value-based surgery in surgical patients throughout Brigham Health.
Dr. Pusic’s research focuses on the measurement of quality of life and patient satisfaction in surgery. Dual training in epidemiology and surgery has enabled her to lead a team of experts in psychometrics, quality of life and social science methods to develop, validate and use new quantitative measures to assess patient outcomes. The patient-reported outcomes instrument she developed for breast surgery, the BREAST-Q, has been widely adopted for research and clinical care and serves as the basis for development of other outcome measures in surgery.
Throughout her career, Dr. Pusic has been involved in research studies that seek to better understand the patient perspective on surgical outcomes and experiences. She is principal investigator of a study funded by the Patient-Centered Outcomes Research Institute (PCORI) that examines how electronic patient-reporting of symptoms may improve surgical care. Altogether, she has been a principal investigator or co-principal investigator on over $10 million in federal research grants.
Dr. Pusic has authored over 200 scientific articles and book chapters and has mentored more than 24 surgeons during various stages of their academic careers. In 2017, she was awarded the Research Achievement Award from the American Society of Plastic Surgeons/Plastic Surgery Foundation. Dr. Pusic is the U.S. Director of Reconstructing Women International and regularly leads surgical camps to provide reconstructive surgery for injured women and girls in the developing world. She is a past board member of the International Society of Quality of Life (ISOQOL) and is currently President of the Plastic Surgery Foundation.
Dr. Christina Rångemark Åkerman is Affiliate Faculty at the Dell Medical School at the University of Texas at Austin, Senior Institute Associate at the Institute for Strategy and Competitiveness (ISC) at Harvard Business School, Member of the Steering Committee of CHES (Coalition for Health, Ethics and Society) at the European Policy Center (EPC), an independent, not-for-profit think tank dedicated to fostering European integration through analysis and debate, and the Chair of The 5612 Group AB, which provides senior advice in the area of patient-centered, sustainable health and care. Until August 2018, she was the President of the International Consortium for Health Outcomes Measurement (ICHOM), a non-profit organization with the purpose to transform health care systems worldwide by measuring and reporting patient outcomes in a standardized way. Between 2008 and 2014, she served as Director General for the Medical Products Agency (MPA) in Sweden, a national agency under the aegis of the Swedish Ministry of Health and Social Affairs. During this period, she was also a Member of the Board of the European Medicines Agency (EMA), which is responsible for the scientific evaluation of medicines for use in the European Union. Before her position with MPA, Christina served as Vice President Medical of AstraZeneca Sweden as well as Marketing Company President of AstraZeneca Philippines. She has also been working chair of start-up companies and on the Board of Fouriertransform, a Swedish state-owned venture capital company. Christina received her medical degree from the University of Linköping. She wrote her doctoral thesis in Clinical Physiology and is a specialist in Clinical Pharmacology. She has an Executive MBA in General Management from the Stockholm School of Economics.
Jens Deerberg-Wittram, MD is the President and CEO of RoMed Health, a regional health system of four hospitals, >1.000 beds and 15 outpatient centers located in southern Germany.
From 2014 to 2018, Jens served as a Director and Global Sector Leader on Value-based Health Care in MedTech at The Boston Consulting Group. From 2002 to 2012, he was CEO of a 15 hospitals, 4.500 beds provider organization in Germany. He has set and implemented a value-based corporate strategy and established a worldwide leading medical outcomes measurement and reporting system.
Since 2009, he closely works on health care strategy and management topics with Professor Michael Porter and Professor Bob Kaplan at Harvard Business School. From 2013 to 2015, he was a faculty member and Senior Fellow at Harvard Business School. Since 2016, Jens is a Senior Institute Associate at the Institute for Strategy and Competitiveness at HBS.
Jens Deerberg-Wittram is the founding President of the International Consortium for Health Outcomes Measurement (ICHOM). He holds a doctorate in Molecular Oncology at the University of Kiel, Germany.